Moreover, ADAMTS9‐AS2 acted as a tumour suppressor that inhibited the progression of GC through regulating the SPOP, and these findings indicated that SPOP and ADAMTS9‐AS2 can be potential targets for GC treatment. Here, ADAMTS9 is linked to gastric cancer.